CVS vs ERNA · P/E 16, rev $402.07B vs P/E 0.0, rev $582.0K
CVS Health Corp (CVS) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CVS and ERNA stock pages for the full models.
Not investment advice.